Position in NVS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$211,711
-$228,782 QoQ
Shares Held
1,386
-56.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BANK OF NOVA SCOTIA holds $1,312,781,180 across 10 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
2,191,725 | $281,636,662 | |
| 2 | JNJ |
Johnson & Johnson
|
886,454 | $225,132,721 | |
| 3 | LLY |
ELI LILLY & Co
|
173,376 | $207,952,392 | |
| 4 | NVO |
Novo Nordisk A S
|
3,065,015 | $146,936,818 | |
| 5 | PFE |
Pfizer Inc
|
4,423,296 | $106,512,967 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
791,956 | $100,055,721 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,726,026 | $99,453,618 | |
| 8 | ABBV |
AbbVie Inc.
|
337,881 | $85,024,374 |
All Filings in NVS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $211,711 | 1,386 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $440,493 | 3,195 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||